查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829821

2025年全球肿瘤消融市场报告

Tumor Ablation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肿瘤消融市场规模迅速扩张，从2024年的14.5亿美元成长至2025年的16.2亿美元，复合年增长率达11.7%。预测期内的成长归因于更精准、更有效率的消融技术的发展、新兴经济体医疗保健支出的增加、人口老化趋势、癌症负担的增加以及全球癌症盛行率的上升。

预计未来几年肿瘤消融市场将快速成长，到2029年将达到24.7亿美元，复合年增长率为11.1%。预测期内的成长归因于癌症盛行率的上升、微创手术的使用增加、应用范围的拓展、医疗保健成本效益的提高以及认知度和教育水平的提高。预测期内的主要趋势包括技术进步、先进消融技术的持续发展、人工智慧的整合、对门诊病人环境的关注以及以患者为中心的诊疗方法。

肿瘤消融是一种微创医疗手术，旨在透过直接向肿瘤施加极热、极冷或化学药物来杀死细胞，从而去除癌组织。这种方法通常用于治疗小肿瘤或位于复杂解剖位置的肿瘤。

肿瘤消融的主要类型包括热消融和化学消融。热感消融利用极高的热量破坏异常或病变组织，并用于各种经皮、经皮和外科手术治疗，治疗乳癌、肝癌、乳癌、肺癌和摄护腺癌等疾病。这些技术的最终用户包括医院、肿瘤中心和其他医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供肿瘤消融市场统计数据，包括全球市场规模、区域份额、肿瘤消融市场份额的竞争对手、详细的肿瘤消融细分市场、市场趋势和商业机会，以及在肿瘤消融行业取得成功所需的数据。本肿瘤消融市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整展望。

未来五年的预测成长率为11.1%，较我们先前对该市场的预测略有下降0.7%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会直接影响美国，导致来自英国和新加坡等主要地区的冷冻消融探针和射频发生器模组的供应链中断，从而导致治疗延迟和肿瘤治疗费用增加。此外，由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

随着微创手术的日益普及，肿瘤消融市场预计将迎来成长。微创手术是指无需切口或仅需小切口的医疗或外科手术干预，与传统手术相比，其优点包括恢復时间更快、併发症风险更低以及术后疼痛减轻。这些手术采用射频、微波或冷冻消融等肿瘤消融技术，在破坏癌组织的同时，最大限度地减少对周围健康组织的损伤，从而进一步缩短患者恢復时间。例如，Intuitive Surgical Inc. 报告称，其支持微创手术的达文西手术系统在 2023 年第四季度的安装量较 2022 年增长了 12%，这进一步支撑了微创手术的发展势头，从而促进了肿瘤消融市场的增长。

肿瘤消融市场的主要企业正专注于技术创新，以提高治疗效果并扩大可治疗肿瘤的范围。创新领域之一是开发骨肿瘤消融系统等专用产品。这些系统专为治疗骨肿瘤的微创手术而设计。美敦力公司（Medtronic plc）的OsteoCool 2.0骨肿瘤消融系统于2024年3月获得FDA 510(k)批准。这款升级版系统专为治疗疼痛性骨转移瘤和良性骨肿瘤（例如骨样骨瘤）而设计。能够同时使用四个内部冷却探头，提高了治疗的灵活性。此系统的高功率同类系统，例如Stryker OptaBlate™骨肿瘤消融系统。

2022年12月，美国生物医药製造公司波士顿科学公司（Boston Scientific Corporation）以5.23亿美元收购了艾科泰克科技控股有限公司（Acotec Scientific Holdings Ltd.）。此次收购将增强波士顿科学公司在中国的业务，并在全球实现艾科泰克科技产品系列的商业化。艾科泰克科技控股有限公司是一家专注于射频消融术技术、药物涂层球囊和血栓抽吸导管的中国医疗科技公司。

肿瘤消融市场包括提供咨询、诊断、化学消融和术后护理等服务的营业单位所获得的收益。市场价值还包括服务提供者销售或包含在服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肿瘤消融：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肿瘤消融市场：成长率分析
  • 全球肿瘤消融市场表现：规模与成长，2019-2024
  • 全球肿瘤消融市场预测：规模与成长，2024-2029年，2034年
  • 全球肿瘤消融：总目标市场（TAM）

第六章 市场细分

  • 全球肿瘤消融市场：按类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 热消融
  • 化学消融
  • 全球肿瘤消融市场（按治疗类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 经皮
  • 腹腔镜
  • 外科手术
  • 全球肿瘤消融市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 肾癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 其他癌症
  • 全球肿瘤消融市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 肿瘤中心
  • 其他最终用户
  • 全球肿瘤消融市场：按热消融类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 射频消融术（RFA）
  • 微波消融（MWA）
  • 冷冻疗法
  • 雷射消熔
  • 高强度聚焦超音波（HIFU）
  • 全球肿瘤消融市场：按化学消融类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 乙醇消融
  • 醋酸消融
  • 基于化疗的消融术（化疗栓塞术）

第七章 区域和国家分析

  • 全球肿瘤消融市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肿瘤消融市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 肿瘤消融市场：竞争格局
  • 肿瘤消融市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Olympus Corporation
  • Terumo Corporation
  • Varian Medical Systems Inc.
  • Merit Medical Systems Inc.
  • Bioventus LLC
  • Accuray Incorporated
  • AtriCure Inc.
  • AngioDynamics Inc.
  • EDAP TMS SA
  • NeuWave Medical Inc.
  • Mirabilis Medical Inc.
  • STARMed Co. Ltd.
  • Profound Medical Corp.
  • RF Medical Co. Ltd.
  • IceCure Medical Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年肿瘤消融市场：提供新机会的国家
  • 2029年肿瘤消融市场：细分领域带来新机会
  • 2029年肿瘤消融市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31428u

Tumor ablation is a minimally invasive medical procedure designed to eliminate cancerous tissues by applying extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This approach is commonly used for treating small tumors or those located in challenging anatomical locations.

The primary types of tumor ablation include thermal ablation and chemical ablation. Thermal ablation involves using extreme heat to destroy abnormal or diseased tissue, and it is employed across various treatments such as percutaneous, laparoscopic, and surgical procedures for conditions such as kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, among others. End users of these techniques include hospitals, oncology centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tumor ablation market research report is one of a series of new reports from The Business Research Company that provides tumor ablation market statistics, including the tumor ablation industry's global market size, regional shares, competitors with a tumor ablation market share, detailed tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation industry. This tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tumor ablation market size has grown rapidly in recent years. It will grow from $1.45 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to the development of more precise and efficient ablation techniques, rising healthcare expenditure across emerging economies, the demographic shift towards older populations, the increasing burden of cancer, and the rising prevalence of cancer globally.

The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.47 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing cancer incidence, growing minimally invasive procedures, expanding applications, increasing healthcare cost-effectiveness, and growing awareness and education. Major trends in the forecast period include technological advancements, Continued development of advanced ablation technologies, integration of artificial intelligence, focus on outpatient settings, and patient-centric approaches.

The forecast of 11.1% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for cryoablation probes and radiofrequency generator modules, sourced from key regions such as the United Kingdom and Singapore, could lead to treatment postponements and increased oncology procedure expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The tumor ablation market is poised for growth due to the increasing adoption of minimally invasive procedures. Minimally invasive procedures involve medical or surgical interventions that require small incisions or no incisions at all, driven by their benefits such as reduced recovery times, lower complication risks, and less post-operative pain compared to traditional surgeries. Tumor ablation techniques, including radiofrequency, microwave, or cryoablation, are employed in these procedures to destroy cancerous tissues while minimizing damage to surrounding healthy tissue, further contributing to quicker recovery times. For example, Intuitive Surgical Inc. reported a 12% increase in placements of da Vinci surgical systems, which facilitate minimally invasive approaches, in the fourth quarter of 2023 compared to 2022, underscoring the momentum behind minimally invasive procedures and, consequently, the tumor ablation market's growth.

Leading companies in the tumor ablation market are focusing on innovation to enhance treatment effectiveness and broaden the scope of treatable tumors. One area of innovation is the development of specialized products such as bone tumor ablation systems. These systems are designed specifically for minimally invasive procedures to treat bone tumors. Recently, Medtronic plc received FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system in March 2024. This upgraded system is tailored for treating painful bone metastases and benign bone tumors such as osteoid osteoma. It allows for the simultaneous use of four internally cooled probes, offering greater flexibility in treatment. The system delivers enhanced power, significantly exceeding that of comparable systems such as the Stryker OptaBlateTM bone tumor ablation system.

In December 2022, Boston Scientific Corporation, a US-based biomedical manufacturing company, acquired Acotec Scientific Holdings Ltd. for $523 million. Through this acquisition, Boston Scientific aims to enhance its presence in China and globally commercialize the product portfolio of Acotec Scientific. Acotec Scientific Holdings Ltd., a China-based medical technology company, specializes in radiofrequency ablation technologies, drug-coated balloons, and thrombus aspiration catheters.

Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor ablation market includes revenues earned by entities by providing services such as consultation, diagnosis, chemical ablation, and post-procedure care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Thermal Ablation; Chemical Ablation
  • 2) By Types Of Treatment: Percutaneous; Laparoscopic; Surgical
  • 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Cancer
  • 4) By End Users: Hospitals; Oncology Centers; Other End Users
  • Subsegments:
  • 1) By Thermal Ablation: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
  • 2) By Chemical Ablation: Ethanol Ablation; Acetic Acid Ablation; Chemotherapy-Based Ablation (Chemoembolization)
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; Varian Medical Systems Inc.; Merit Medical Systems Inc.; Bioventus LLC; Accuray Incorporated; AtriCure Inc.; AngioDynamics Inc.; EDAP TMS S.A.; NeuWave Medical Inc.; Mirabilis Medical Inc.; STARMed Co. Ltd.; Profound Medical Corp.; RF Medical Co. Ltd.; IceCure Medical Ltd.; MedWaves Inc.; Chongqing Haifu Medical Technology Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Ablation Market Characteristics

3. Tumor Ablation Market Trends And Strategies

4. Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Ablation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Ablation Market Growth Rate Analysis
  • 5.4. Global Tumor Ablation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Ablation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Ablation Total Addressable Market (TAM)

6. Tumor Ablation Market Segmentation

  • 6.1. Global Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thermal Ablation
  • Chemical Ablation
  • 6.2. Global Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Percutaneous
  • Laparoscopic
  • Surgical
  • 6.3. Global Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer
  • 6.4. Global Tumor Ablation Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Oncology Centers
  • Other End Users
  • 6.5. Global Tumor Ablation Market, Sub-Segmentation Of Thermal Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation (RFA)
  • Microwave Ablation (MWA)
  • Cryoablation
  • Laser Ablation
  • High-Intensity Focused Ultrasound (HIFU)
  • 6.6. Global Tumor Ablation Market, Sub-Segmentation Of Chemical Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ethanol Ablation
  • Acetic Acid Ablation
  • Chemotherapy-Based Ablation (Chemoembolization)

7. Tumor Ablation Market Regional And Country Analysis

  • 7.1. Global Tumor Ablation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Ablation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Ablation Market

  • 8.1. Asia-Pacific Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Ablation Market

  • 9.1. China Tumor Ablation Market Overview
  • 9.2. China Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Ablation Market

  • 10.1. India Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Ablation Market

  • 11.1. Japan Tumor Ablation Market Overview
  • 11.2. Japan Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Ablation Market

  • 12.1. Australia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Ablation Market

  • 13.1. Indonesia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Ablation Market

  • 14.1. South Korea Tumor Ablation Market Overview
  • 14.2. South Korea Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Ablation Market

  • 15.1. Western Europe Tumor Ablation Market Overview
  • 15.2. Western Europe Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Ablation Market

  • 16.1. UK Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Ablation Market

  • 17.1. Germany Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Ablation Market

  • 18.1. France Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Ablation Market

  • 19.1. Italy Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Ablation Market

  • 20.1. Spain Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Ablation Market

  • 21.1. Eastern Europe Tumor Ablation Market Overview
  • 21.2. Eastern Europe Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Ablation Market

  • 22.1. Russia Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Ablation Market

  • 23.1. North America Tumor Ablation Market Overview
  • 23.2. North America Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Ablation Market

  • 24.1. USA Tumor Ablation Market Overview
  • 24.2. USA Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Ablation Market

  • 25.1. Canada Tumor Ablation Market Overview
  • 25.2. Canada Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Ablation Market

  • 26.1. South America Tumor Ablation Market Overview
  • 26.2. South America Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Ablation Market

  • 27.1. Brazil Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Ablation Market

  • 28.1. Middle East Tumor Ablation Market Overview
  • 28.2. Middle East Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Ablation Market

  • 29.1. Africa Tumor Ablation Market Overview
  • 29.2. Africa Tumor Ablation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Ablation Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Ablation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Ablation Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Ablation Market Competitive Landscape
  • 30.2. Tumor Ablation Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Ablation Market Other Major And Innovative Companies

  • 31.1. Olympus Corporation
  • 31.2. Terumo Corporation
  • 31.3. Varian Medical Systems Inc.
  • 31.4. Merit Medical Systems Inc.
  • 31.5. Bioventus LLC
  • 31.6. Accuray Incorporated
  • 31.7. AtriCure Inc.
  • 31.8. AngioDynamics Inc.
  • 31.9. EDAP TMS S.A.
  • 31.10. NeuWave Medical Inc.
  • 31.11. Mirabilis Medical Inc.
  • 31.12. STARMed Co. Ltd.
  • 31.13. Profound Medical Corp.
  • 31.14. RF Medical Co. Ltd.
  • 31.15. IceCure Medical Ltd.

32. Global Tumor Ablation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Market

34. Recent Developments In The Tumor Ablation Market

35. Tumor Ablation Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Ablation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Ablation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Ablation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer